The bill modifies and extends the appropriation for the long-term safety net insulin program in Minnesota. It amends the existing law to allocate $297,000 from the health care access fund for the insulin safety net program, extending the availability of these funds until June 30, 2027. Additionally, it appropriates $250,000 for a public awareness campaign related to the program and maintains funding for the Board of Pharmacy and the commissioner of health to implement and assess the program's effectiveness.

Importantly, the bill repeals the sunset provision for the long-term safety net insulin program, which previously mandated a legislative review by December 31, 2024, to determine the program's necessity. This repeal means that the program will continue without a predetermined expiration date, allowing for ongoing support for Minnesota residents in need of affordable insulin. The effective date of this repeal is the day following the final enactment of the bill.

Statutes affected:
Introduction: 151.74
1st Engrossment: 151.74